These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2313164)

  • 21. Adrenal neural transplants in Parkinson's disease.
    Koller WC; Waxman M; Morantz R
    Adv Neurol; 1990; 53():559-65. PubMed ID: 2239496
    [No Abstract]   [Full Text] [Related]  

  • 22. Adrenal to caudate transplantation--postmortem study.
    Waters C; Itabashi HH; Apuzzo ML; Weiner LP
    Mov Disord; 1990; 5(3):248-50. PubMed ID: 2388643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenal medullary tissue transplantation in Parkinson's disease: a review.
    Burns RS; Allen GS; Tulipan NB
    Adv Neurol; 1990; 53():571-6. PubMed ID: 2239498
    [No Abstract]   [Full Text] [Related]  

  • 24. [Met-enkephalin and substance P. Comparison of CSF levels in patients with chronic pain based on a sampling procedure].
    Guieu R; Tardy-Gervet MF; Giraud P; Boudouresque F
    Rev Neurol (Paris); 1993; 149(6-7):398-401. PubMed ID: 7508141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation in the treatment of paralysis agitans (Parkinson's disease).
    Fazzini E
    J Am Osteopath Assoc; 1992 Oct; 92(10):1255-60. PubMed ID: 1459872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The concentration of homovanillic acid and leucine-enkephalin in the lumbar CSF of patients with Parkinson's disease before and after madopar treatment].
    Liu DK
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Apr; 22(2):95-8, 126-7. PubMed ID: 2791764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropathological study 16 years after autologous adrenal medullary transplantation in a Parkinson's disease patient.
    Kompoliti K; Chu Y; Shannon KM; Kordower JH
    Mov Disord; 2007 Aug; 22(11):1630-3. PubMed ID: 17534949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal medullary autografts in patients with Parkinson's disease.
    N Engl J Med; 1989 Aug; 321(5):324-7. PubMed ID: 2747774
    [No Abstract]   [Full Text] [Related]  

  • 29. Parkinson's disease: autotransplantation of adrenal medulla to caudate nucleus of the brain.
    Williams V
    J Neurosci Nurs; 1987 Jun; 19(3):174. PubMed ID: 2956339
    [No Abstract]   [Full Text] [Related]  

  • 30. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease.
    Goetz CG; Olanow CW; Koller WC; Penn RD; Cahill D; Morantz R; Stebbins G; Tanner CM; Klawans HL; Shannon KM
    N Engl J Med; 1989 Feb; 320(6):337-41. PubMed ID: 2643770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?
    Hirsch EC; Duyckaerts C; Javoy-Agid F; Hauw JJ; Agid Y
    Ann Neurol; 1990 Jun; 27(6):676-82. PubMed ID: 2360804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal neuropeptide Y and substance P in suicide attempters during long-term antidepressant treatment.
    Olsson A; Regnéll G; Träskman-Bendz L; Ekman R; Westrin A
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):479-85. PubMed ID: 15589387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal medulla autografts in Parkinson's disease: a proposed mechanism of action.
    Riopelle RJ
    Can J Neurol Sci; 1988 Nov; 15(4):366-70. PubMed ID: 3061629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla.
    Stoddard SL; Tyce GM; Ahlskog JE; Zinsmeister AR; Nelson DK; Carmichael SW
    Exp Neurol; 1991 Oct; 114(1):23-7. PubMed ID: 1915731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of adrenal medullary and fetal grafts as a treatment for Parkinson disease.
    Lieberman AN
    N Y State J Med; 1988 Jun; 88(6):287-9. PubMed ID: 3405498
    [No Abstract]   [Full Text] [Related]  

  • 36. Functional improvement by transplanting auto-adrenal medulla grafts into caudate in patients with parkinsonism.
    Ding YJ; Zhang WC; Jiao SS; Cao JK; Meng JM; Ding MC; Sun JB; Zhang ZM; Shi MT
    Chin Med J (Engl); 1988 Sep; 101(9):631-6. PubMed ID: 3148405
    [No Abstract]   [Full Text] [Related]  

  • 37. CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration.
    Yasui K; Inoue Y; Kanbayashi T; Nomura T; Kusumi M; Nakashima K
    J Neurol Sci; 2006 Dec; 250(1-2):120-3. PubMed ID: 17005202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenal medulla autograft in caudate nucleus as treatment for Parkinson disease.
    Broggi G; Pluchino F; Gennari L; Geminiani S; Tamma F; Caraceni T
    Acta Neurochir Suppl (Wien); 1991; 52():45-7. PubMed ID: 1792965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adrenal transplantation and Parkinson's disease].
    Luquin MR; Legarda I; Guillén J; Rodríguez MC; Martínez-Lage JM
    Rev Med Univ Navarra; 1994; 38(4):174-80. PubMed ID: 8992595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF serotonin, 5-hydroxyindolacetic acid and neuropeptide Y levels in severe major depressive disorder.
    Hou C; Jia F; Liu Y; Li L
    Brain Res; 2006 Jun; 1095(1):154-8. PubMed ID: 16713589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.